Reported about 9 hours ago
Craig Hallum has initiated a 'Buy' rating for Dyadic International, Inc. (NASDAQ:DYAI) with a price target of $5.00, indicating a potential upside of 405.7%. The firm praises Dyadic's new focus on commercializing its proprietary technology for protein production after years of R&D, signaling a strong shift towards practical applications which may yield $100 million in profits over the next five years. The company's management is optimistic about its future, having reached a commercial inflection point to effectively compete in the biotechnology market.
Source: YAHOO